コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 een for serum TSH concentration >5 mIUL(-1) (hypothyroidism).
2 had elevated thyroid manganese and developed hypothyroidism.
3 p toward cell-based regenerative therapy for hypothyroidism.
4 role for additional signaling modulators in hypothyroidism.
5 ported a diagnosis of subclinical autoimmune hypothyroidism.
6 ly lost in autoimmune thyroiditis leading to hypothyroidism.
7 adult rodents following prolonged (12 week) hypothyroidism.
8 and 18% in 141 individuals with subclinical hypothyroidism.
9 ith time and dose, likely in compensation to hypothyroidism.
10 ary hypogonadism, adrenal insufficiency, and hypothyroidism.
11 m, proteinuria, reduced kidney function, and hypothyroidism.
12 those affected ultimately develop permanent hypothyroidism.
13 tion, thus creating a state of cell-specific hypothyroidism.
14 n resistance by promoting centrally mediated hypothyroidism.
15 were hearing loss, psychiatric effects, and hypothyroidism.
16 dominantly resulting in blood cytopenias and hypothyroidism.
17 mia, high creatinine, history of stroke, and hypothyroidism.
18 subclinical hyperthyroidism and subclinical hypothyroidism.
19 thyroid hormone levels and of serum PFOA and hypothyroidism.
20 dwh, that rescues hearing despite persistent hypothyroidism.
21 estimate hazard ratios (HRs) and 95% CIs for hypothyroidism.
22 ations in thyroid architecture, and dramatic hypothyroidism.
23 oidism (OR(adj) = 2.3 (95% CI: 1.2, 4.4) and hypothyroidism.
24 1.1, 2.8) was significantly associated with hypothyroidism.
25 mone receptor (TR) during development and in hypothyroidism.
26 eutic targets in the treatment of congenital hypothyroidism.
27 mediates repression by the unliganded TR in hypothyroidism.
28 ression of betaMHC in response to stress and hypothyroidism.
29 ings that accompany both hyperthyroidism and hypothyroidism.
30 g data in patients suffering from congenital hypothyroidism.
31 etabolic differences between mild and severe hypothyroidism.
32 icating that Slc30a10 knock-out mice develop hypothyroidism.
33 yroid participants or those with subclinical hypothyroidism.
34 story was significant for hyperlipidemia and hypothyroidism.
35 t benefits in older persons with subclinical hypothyroidism.
36 ssociated with the development of congenital hypothyroidism.
37 s been used for more than a century to treat hypothyroidism.
38 n diet, thiamine deficiency, alcoholism, and hypothyroidism.
39 Thyroidectomized rats with serum-confirmed hypothyroidism 1 month after surgery were randomized int
40 High-yield tests included thyroid function (hypothyroidism, 10.1%), audiometry (hearing loss, 22.6%)
41 ere were 13 (9.8%) with a prior diagnosis of hypothyroidism, 11 of whom were receiving thyroxine ther
43 nic constipation (prevalence 14.2% vs 3.6%), hypothyroidism (14.7% vs 10.4%), obesity (13.0% vs 7.7%)
44 sease (HR 1.93, 95% CI 1.76-2.12; p<0.0001), hypothyroidism (2.31, 2.05-2.60; p<0.0001), and raised t
46 t common immune-mediated adverse events were hypothyroidism (25 [16%]) and hyperthyroidism (17 [11%])
47 8 [19%]), dysphonia (44 [23%] vs ten [10%]), hypothyroidism (39 [21%] vs seven [7%]), and upper abdom
51 oration (4%-9%), photosensitivity (25%-75%), hypothyroidism (6%), hyperthyroidism (0.9%-2%), pulmonar
53 cellular carcinoma, severe anemia, untreated hypothyroidism, Addison syndrome and major depression be
55 a (adjusted OR = 1.5; 95% CI = 1.4-1.6), and hypothyroidism (adjusted OR = 1.2; 95% CI = 1.1-1.4).
57 ecific NEMO knock-out mice gradually develop hypothyroidism after birth, which leads to reduced body
58 he odds of MCI with clinical and subclinical hypothyroidism among men was 1.02 (95% CI, 0.57-1.82) an
59 f interest, thyroid dysfunction (10 cases of hypothyroidism and 1 of Graves disease) developed in 11
60 s of follow-up), 1958 (6.5%) had subclinical hypothyroidism and 2574 individuals (8.6%) developed AF
61 90 participants, 2068 (8.1%) had subclinical hypothyroidism and 648 (2.6%) had subclinical hyperthyro
63 ng development results in maternal and fetal hypothyroidism and associated serious adverse health eff
65 t HDAC inhibitors are clearly beneficial for hypothyroidism and could be therapeutics for treatment.
66 1/5(dKO)) mice displayed growth retardation, hypothyroidism and defective follicular architecture.
68 ignificant elevated risk association between hypothyroidism and HCC in women that was independent of
70 indicated a significant association between hypothyroidism and HCC, with an approximate two-fold to
71 ween ever use of organochlorines and risk of hypothyroidism and hyperthyroidism among female spouses
73 eatment of subclinical and undiagnosed overt hypothyroidism and hyperthyroidism in adults without goi
76 thyroid disease was 12.5%, and prevalence of hypothyroidism and hyperthyroidism was 6.9% and 2.1%, re
77 dence suggests that milder forms of maternal hypothyroidism and hypothyroxinemia during pregnancy are
78 ever, its use can cause side effects such as hypothyroidism and increased triglyceride concentrations
80 evant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency ar
81 e investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1
83 association between clinical or subclinical hypothyroidism and MCI (odds ratio [OR], 0.99 [95% CI, 0
84 onstrated an association between subclinical hypothyroidism and metabolic syndrome and selected compo
86 ntiating transient from permanent congenital hypothyroidism and predicting the response of patients t
89 These mice provide a new model of central hypothyroidism and reveal a critical role for D3 in the
90 ll increase in the prevalence of subclinical hypothyroidism and thyroid autoimmunity; whether these i
91 , isolated cleft lip and cleft palate (CLP), hypothyroidism and thyroid cancer all map to the FOXE1 l
92 etermine the mechanisms of manganese-induced hypothyroidism and understand how SLC30A10 and SLC39A14
94 chemotherapy with cediranib, and diarrhoea, hypothyroidism and voice changes were more common during
95 thyroidism, 1.4% primary and 0.1% iatrogenic hypothyroidism, and 1.3% other/unspecified thyroid disea
96 d function, 17% in 313 persons with clinical hypothyroidism, and 18% in 141 individuals with subclini
97 be caused by medications use, renal failure, hypothyroidism, and by prolactinoma - PRL secreting tumo
98 than 50% of women with previously diagnosed hypothyroidism, and can be managed by increasing the lev
100 s mellitus, myopathy, pulmonary dysfunction, hypothyroidism, and death increased as time off cysteami
101 okers, have a history of hemorrhagic stroke, hypothyroidism, and dementia, and less likely to be trea
102 scabies, chronic mucocutaneous candidiasis, hypothyroidism, and esophageal squamous cell carcinoma.
103 one case each of grade 3 pemphigoid, grade 3 hypothyroidism, and grade 3 peripheral sensory neuropath
105 e studied 3 sisters with primary amenorrhea, hypothyroidism, and hypergonadotropic hypogonadism.
106 of human kindreds suffering from congenital hypothyroidism, and in the cog congenital goiter mouse a
107 of CD40 on TECs, development of fibrosis and hypothyroidism, and increased expression of proinflammat
108 hypothyroidism is more common than is overt hypothyroidism, and is usually defined as a serum thyroi
109 matic mutation carriers at risk of recurrent hypothyroidism, and provides a rationale for adjunct iod
110 en were found with autoimmune thyroiditis or hypothyroidism, and replacement therapy was initiated in
111 ase, obesity, hyperlipidemia, renal disease, hypothyroidism, and the number of outpatient visits for
114 of the genomic changes mediated by the TR in hypothyroidism are independent of NCoR1, suggesting a ro
117 -subclinical hyperthyroidism and subclinical hypothyroidism--are common clinical entities that encomp
119 serum TSH between 5 and 10 mIU/L, and overt hypothyroidism as a serum TSH greater than 10 mIU/L, but
120 ding hypertension and indicate developmental hypothyroidism as an epigenetic risk factor for cardiova
121 ne (TSH) 0.45 to 4.49 mIU/L, and subclinical hypothyroidism as TSH 4.5 to 19.9 mIU/L with free thyrox
122 ed as TSH of 0.45 to 4.49 mIU/L, subclinical hypothyroidism as TSH of 4.5 to 19.9 mIU/L, and subclini
123 of developing autoimmune diseases, including hypothyroidism, as seen with cancer patients undergoing
124 d CD had increased rates of osteoporosis and hypothyroidism, as well as lower body mass index and lev
126 pecific TRbeta1-KO mice, we demonstrate that hypothyroidism-associated changes in gene expression and
127 orticotropic hormone deficiency, and primary hypothyroidism at 4 years from diagnosis was 93% +/- 4%,
128 rium at 9q22 near FOXE1 were associated with hypothyroidism at genome-wide significance, the stronges
129 glucose/galactose malabsorption, congenital hypothyroidism, Bartter's syndrome, epilepsy, depression
131 Severe iodine deficiency causes goitre and hypothyroidism because, despite an increase in thyroid a
132 s in pubertal timing, development of primary hypothyroidism, breast cancer as a second malignant neop
136 Vision and hearing disorders as well as hypothyroidism can negatively impact cognitive functioni
137 evothyroxine, which is usually used to treat hypothyroidism, can be considered in such situations.
141 ype mice, the bacterial components induced a hypothyroidism characterized by elements of both hypotha
142 st thyroglobulin, and development of primary hypothyroidism (decreased levels of serum thyroxin, and
143 before 20 weeks of gestation for subclinical hypothyroidism, defined as a thyrotropin level of 4.00 m
144 e-treated patients with residual symptoms of hypothyroidism despite normalization of the serum TSH ha
146 1.02-1.24) for children born to mothers with hypothyroidism diagnosed before and after delivery, comp
147 ren, 3524 children were born to mothers with hypothyroidism diagnosed before delivery and 4664 diagno
148 observed among children born to mothers with hypothyroidism diagnosed before delivery who did not rec
151 12 weeks 3 days) and maternal treatment for hypothyroidism did not result in improved cognitive func
152 adequate evidence that treating subclinical hypothyroidism does not provide clinically meaningful im
158 and surrounding tissues leading to profound hypothyroidism, findings consistent with our in vitro re
162 each had grade 3 rhabdomyolysis and grade 2 hypothyroidism; grade 3 iridocyclitis, grade 1 erythema
163 we describe a child with classic features of hypothyroidism (growth retardation, developmental retard
165 Specifically, individuals with subclinical hypothyroidism had an adjusted hazard ratio of 1.07 (95%
169 rs7850258 allele (G) associated with CLP and hypothyroidism has significantly greater enhancer activi
170 he effects of antiepileptic drugs in central hypothyroidism have not yet been studied, substantial ev
171 ed with survivors not so exposed for primary hypothyroidism (hazard ratio [HR], 6.6; 95% CI, 5.6 to 7
173 ipheral neuropathy were evaluated: diabetes, hypothyroidism, hypercholesterolemia, hypertension, vari
175 sk of reduced urinary concentrating ability, hypothyroidism, hyperparathyroidism, and weight gain.
176 positive associations with antibody-positive hypothyroidism, hyperthyroidism, AIT, or elevated ATPO.
177 sterol, renal impairment, diabetes, obesity, hypothyroidism, hyperthyroidism, anaemia, respiratory di
178 associated with an increased odds ratio for hypothyroidism, hyperthyroidism, and antithyroid antibod
179 rral, knowledge of the signs and symptoms of hypothyroidism, hyperthyroidism, and thyroid nodules, as
180 We conducted a cross-sectional analysis of hypothyroidism, hyperthyroidism, autoimmune thyroiditis
181 regression models compared risks of primary hypothyroidism, hyperthyroidism, thyroid neoplasms, hypo
182 n, radiological assessment, and treatment of hypothyroidism, hyperthyroidism, thyroid nodules, and th
183 gan toxicity has been limited to correctable hypothyroidism in 42% of irradiated patients, and one ca
184 ts developing after transplantation included hypothyroidism in 5 subjects and enteritis in 1 subject.
185 r radiotherapy were asymptomatic compensated hypothyroidism in 9 patients (10%), osteonecrosis and mo
188 d mice developed multiple autoantibodies and hypothyroidism in contrast to mice treated with bone mar
190 d mutations in the ChEL domain to congenital hypothyroidism in humans and rodents; these mutations bl
193 Genetic disruption of KCNQ1-KCNE2 causes hypothyroidism in mice, resulting in cardiac hypertrophy
194 oid hormone receptor alpha gene (THRA) cause hypothyroidism in patients with growth and developmental
195 We tested the hypothesis that the severe hypothyroidism in patients with THRA mutations is due to
197 h has focused on detection and management of hypothyroidism in pregnancy, and consequences of hypothy
198 Early detection and appropriate treatment of hypothyroidism in pregnant women may be an area for poss
199 2320R mutation is responsible for congenital hypothyroidism in rdw/rdw rats, in which a lack of secon
200 presents a spontaneous, inherited recessive hypothyroidism in Sprague-Dawley rats with devastating f
202 terest in the possible link between maternal hypothyroidism in the perinatal period and childhood ast
205 omponents, whole immunoglobulins induced NTI hypothyroidism in wild-type mice, but not in those lacki
208 genetic complexity of protective effects on hypothyroidism-induced hearing impairment, an F1 intercr
211 Our results show that the pathogenesis of hypothyroidism-induced NAFLD is both intra- and extrahep
212 yndrome, hemolytic anemia, thrombocytopenia, hypothyroidism, inflammatory myositis, Raynaud's disease
213 ge (identical to that causing human goitrous hypothyroidism) inhibits this maturation, although the C
214 in NLGN) mutation responsible for congenital hypothyroidism into NLGN3, we show that mutations in the
221 ociated with HLA SNP variation and show that hypothyroidism is genetically correlated with Type I dia
222 ormone accelerates energy expenditure; thus, hypothyroidism is intuitively associated with obesity.
224 The current treatment for patients with hypothyroidism is levothyroxine (L-T4) along with normal
230 ologic disorders, chronic pulmonary disease, hypothyroidism, liver disease, AIDS, coagulopathy, defic
231 cant positive associations of 131I dose with hypothyroidism (mainly subclinical and antibody-negative
232 n, these findings suggest that developmental hypothyroidism may be the cause of cardiovascular disord
233 iodine deficiency-related maternal and child hypothyroidism may cause severe mental retardation, rece
236 mic immune-mediated complications, including hypothyroidism (n = 3), colitis (n = 2), and hepatitis (
241 We also report novel SNP associations for hypothyroidism near HLA-DQA1/HLA-DQB1 at rs6906021 (comb
242 ther features, including ichthyosis, primary hypothyroidism, neurological symptoms, and cryptorchidis
246 sease was associated with increased rates of hypothyroidism (odds ratio, 2.2; P < .01) and a lower th
249 Sixty-three (47.4%) had a prior diagnosis of hypothyroidism or autoimmune thyroiditis, of whom 56 wer
251 men who are identified as having subclinical hypothyroidism or hypothyroxinemia during pregnancy impr
252 eening of all pregnant women for subclinical hypothyroidism or thyroid autoimmunity is not recommende
254 The strongest association in the PheWAS was hypothyroidism (OR = 0.76, p = 2.7 x 10(-13)), which had
255 .12; (95% CI: 0.83, 1.52) (n=105 cases); for hypothyroidism, OR=1.35 (95% CI: 0.86, 2.13) (n=49 cases
256 ted with endocrine or metabolic abnormality (hypothyroidism, panhypopituitarism and renal rickets).
259 , we characterize a mouse model of secondary hypothyroidism, pituitary transcription factor 1 (Pit1(d
262 perspectives on whether treating subclinical hypothyroidism reduces morbidity and mortality, whether
264 -specific iPSCs generated from patients with hypothyroidism resulting from NKX2-1 haploinsufficiency.
265 valuate the relationship between subclinical hypothyroidism (SCH) and all-cause and cardiovascular di
266 Monotherapy Fails to Restore All Markers of Hypothyroidism" should read "new technology is needed to
267 ariates-prolonged hyperthyroidism, prolonged hypothyroidism, smoking, treatment with an antithyroid d
268 ss the epidemiology, causes, and symptoms of hypothyroidism; summarise evidence on diagnosis, long-te
269 those of patients with neonatal diabetes and hypothyroidism syndrome, including the development of di
271 rs of age and who had persisting subclinical hypothyroidism (thyrotropin level, 4.60 to 19.99 mIU per
272 fferent thyroid hormone levels, ranging from hypothyroidism to hyperthyroidism on AF inducibility in
273 ataplexy, hypocretin deficiency, and central hypothyroidism, together with brainstem encephalitis ref
274 ism did not affect graft function, but acute hypothyroidism transiently impaired human C-peptide secr
278 rt study found that treatment of subclinical hypothyroidism was associated with decreased risk for co
279 e analyzed, an increased risk of subclinical hypothyroidism was associated with high blood pressure (
291 .2 years, the incident rates for subclinical hypothyroidism were substantially higher in participants
292 cases distinguishing between NTIS and severe hypothyroidism, which is a rare primary cause for admiss
293 at a greater risk for developing subclinical hypothyroidism, while its mechanisms and temporal conseq
296 TBMEHP exposure in the rat produced maternal hypothyroidism with markedly decreased serum T3 (3,3 ,5-
298 An association of clinical and subclinical hypothyroidism with mild cognitive impairment (MCI) has
300 to adulthood, D3KO mice demonstrate central hypothyroidism, with low serum levels of 3,5,3',5'-tetra
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。